The 2006 Plan permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 3,439,000. As of July 31, 2026, there were 1,082,496 shares of Common Stock or Class B Stock available for future grants under this plan.

All non-vested restricted stock as of July 31, 2026, was issued under the 2006 Plan with vesting periods generally from one to five years. The fair value of restricted stock was determined by the closing market price of our Common Stock on the date of grant multiplied by the number of shares granted. Fair value of shares vested in fiscal years 2026, 2025, and 2024 is $12.3 million, $6.6 million, and $9.8 million, respectively as of their vesting dates.


	Number of Shares (in thousands)	Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Term (Years)	Unamortized Expense (in thousands)
Non-vested restricted stock outstanding at July 31, 2023	696	$	16.48	2.3	$	5,129
Granted	429	$	31.53
Vested	(307)	$	15.68
Forfeited	(23)	$	19.54
Non-vested restricted stock outstanding at July 31, 2024	795	$	24.82	3.4	$	13,360
Granted	143	$	38.29
Vested	(183)	$	20.17
Forfeited	(27)	$	27.76
Non-vested restricted stock outstanding at July 31, 2025	728	$	28.52	3.0	$	12,713
Granted	74	$	58.26
Vested	(209)	$	21.40
Forfeited	(12)	$	33.97
Non-vested restricted stock outstanding at July 31, 2026	581	$	34.74	2.7	$	11,316

Stock-based compensation for restricted stock of $4.0 million, $4.1 million, and $3.7 million, net of related tax effect, was recognized in fiscal years 2026, 2025, and 2024, respectively. The total restricted stock compensation related tax benefit was $1.3 million, $1.3 million, and $1.2 million in fiscal years 2026, 2025, and 2024, respectively.